ID   CHRR_ECOLI              Reviewed;         188 AA.
AC   P0AGE6; P31465; Q2M831;
DT   20-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   20-DEC-2005, sequence version 1.
DT   15-FEB-2017, entry version 89.
DE   RecName: Full=Chromate reductase;
DE            Short=CHRR;
DE            EC=1.6.5.2;
DE   AltName: Full=NAD(P)H dehydrogenase (quinone);
GN   Name=chrR; Synonyms=yieF; OrderedLocusNames=b3713, JW3691;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=7686882; DOI=10.1006/geno.1993.1230;
RA   Burland V.D., Plunkett G. III, Daniels D.L., Blattner F.R.;
RT   "DNA sequence and analysis of 136 kilobases of the Escherichia coli
RT   genome: organizational symmetry around the origin of replication.";
RL   Genomics 16:551-561(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, SUBSTRATE
RP   SPECIFICITY, ENZYME REGULATION, INDUCTION, AND COFACTOR.
RX   PubMed=14766567; DOI=10.1128/AEM.70.2.873-882.2004;
RA   Ackerley D.F., Gonzalez C.F., Park C.H., Blake R. II, Keyhan M.,
RA   Matin A.;
RT   "Chromate-reducing properties of soluble flavoproteins from
RT   Pseudomonas putida and Escherichia coli.";
RL   Appl. Environ. Microbiol. 70:873-882(2004).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   MUTAGENESIS OF TYR-128.
RX   PubMed=17088379; DOI=10.1128/AEM.01334-06;
RA   Barak Y., Ackerley D.F., Dodge C.J., Banwari L., Alex C.,
RA   Francis A.J., Matin A.;
RT   "Analysis of novel soluble chromate and uranyl reductases and
RT   generation of an improved enzyme by directed evolution.";
RL   Appl. Environ. Microbiol. 72:7074-7082(2006).
RN   [6]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=16621832; DOI=10.1128/JB.188.9.3371-3381.2006;
RA   Ackerley D.F., Barak Y., Lynch S.V., Curtin J., Matin A.;
RT   "Effect of chromate stress on Escherichia coli K-12.";
RL   J. Bacteriol. 188:3371-3381(2006).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 3-188 IN COMPLEX WITH FMN,
RP   FUNCTION, CATALYTIC ACTIVITY, MUTAGENESIS OF TYR-85; ARG-125 AND
RP   GLU-146, AND SUBUNIT.
RC   STRAIN=K12;
RX   PubMed=22558308; DOI=10.1371/journal.pone.0036017;
RA   Eswaramoorthy S., Poulain S., Hienerwadel R., Bremond N.,
RA   Sylvester M.D., Zhang Y.B., Berthomieu C., Van Der Lelie D., Matin A.;
RT   "Crystal structure of ChrR--a quinone reductase with the capacity to
RT   reduce chromate.";
RL   PLoS ONE 7:E36017-E36017(2012).
CC   -!- FUNCTION: Involved in the protection against chromate toxicity.
CC       Catalyzes the transfer of three electrons to Cr(6+) producing
CC       Cr(3+) and one electron to molecular oxygen without producing the
CC       toxic Cr(5+) species and only producing a minimal amount of
CC       reactive oxygen species (ROS). It can also reduce quinones,
CC       potassium ferricyanide, 2,6-dichloroindophenol, V(5+), Mo(6+),
CC       methylene blue and cytochrome c. The quinone reductase activity
CC       may protect against oxidative stress by preventing redox cycling
CC       of quinones which would otherwise generate ROS and by maintaining
CC       a pool of reduced quinone in the cell that is able to quench ROS
CC       directly. It is able to use both NAD or NADP equally well.
CC       {ECO:0000269|PubMed:14766567, ECO:0000269|PubMed:16621832,
CC       ECO:0000269|PubMed:17088379, ECO:0000269|PubMed:22558308}.
CC   -!- CATALYTIC ACTIVITY: NAD(P)H + a quinone = NAD(P)(+) + a
CC       hydroquinone.
CC   -!- CATALYTIC ACTIVITY: 2 NAD(P)H + Cr(6+) + O(2) = 2 NAD(P)(+) +
CC       Cr(3+) + H(2)O(2).
CC   -!- COFACTOR:
CC       Name=FMN; Xref=ChEBI:CHEBI:58210;
CC         Evidence={ECO:0000269|PubMed:14766567};
CC       Note=Binds 1 FMN per subunit. {ECO:0000269|PubMed:14766567};
CC   -!- ENZYME REGULATION: Inhibited by divalent cations.
CC       {ECO:0000269|PubMed:14766567}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=108 uM for uranate (at pH 7 and 37 degrees Celsius.
CC         PubMed:17088379) {ECO:0000269|PubMed:14766567,
CC         ECO:0000269|PubMed:17088379};
CC         KM=200 uM for chromate (at pH 5 and 35 degrees Celsius.
CC         PubMed:14766567) {ECO:0000269|PubMed:14766567,
CC         ECO:0000269|PubMed:17088379};
CC         KM=376 uM for chromate (at pH 7 and 37 degrees Celsius.
CC         PubMed:17088379) {ECO:0000269|PubMed:14766567,
CC         ECO:0000269|PubMed:17088379};
CC         Vmax=5 umol/min/mg enzyme with chromate as substrate (at pH 5
CC         and 35 degrees Celsius. PubMed:14766567)
CC         {ECO:0000269|PubMed:14766567, ECO:0000269|PubMed:17088379};
CC         Vmax=213 umol/min/mg enzyme with uranate as substrate (at pH 7
CC         and 37 degrees Celsius. PubMed:17088379)
CC         {ECO:0000269|PubMed:14766567, ECO:0000269|PubMed:17088379};
CC         Vmax=295 umol/min/mg enzyme with chromate as substrate (at pH 7
CC         and 37 degrees Celsius. PubMed:17088379)
CC         {ECO:0000269|PubMed:14766567, ECO:0000269|PubMed:17088379};
CC         Note=Kcat is 3.7 sec(-1) for reductase activity with chromate
CC         (at pH 5 and 35 degrees Celsius. PubMed:14766567). Kcat is 29
CC         sec(-1) for reductase activity with uranate (at pH 7 and 37
CC         degrees Celsius. PubMed:17088379). Kcat is 30 sec(-1) for
CC         reductase activity with chromate (at pH 7 and 37 degrees
CC         Celsius. PubMed:17088379).;
CC       pH dependence:
CC         Optimum pH is 5. {ECO:0000269|PubMed:14766567,
CC         ECO:0000269|PubMed:17088379};
CC       Temperature dependence:
CC         Optimum temperature is 35 degrees Celsius.
CC         {ECO:0000269|PubMed:14766567, ECO:0000269|PubMed:17088379};
CC   -!- SUBUNIT: Homotetramer. Dimer of dimers. The tetrameric
CC       configuration has a central role in chromate reductase activity.
CC       {ECO:0000269|PubMed:22558308}.
CC   -!- INDUCTION: Induced by both chromate and the stationary phase.
CC       {ECO:0000269|PubMed:14766567}.
CC   -!- DISRUPTION PHENOTYPE: Cells lacking this gene show an increased
CC       sensitivity to chromate. {ECO:0000269|PubMed:16621832}.
CC   -!- SIMILARITY: Belongs to the SsuE family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L10328; AAA62064.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC76736.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAE77575.1; -; Genomic_DNA.
DR   PIR; B65174; B65174.
DR   RefSeq; NP_418169.1; NC_000913.3.
DR   RefSeq; WP_001291268.1; NZ_LN832404.1.
DR   PDB; 3SVL; X-ray; 2.20 A; A/B=3-188.
DR   PDBsum; 3SVL; -.
DR   ProteinModelPortal; P0AGE6; -.
DR   SMR; P0AGE6; -.
DR   BioGrid; 4262171; 9.
DR   DIP; DIP-36041N; -.
DR   IntAct; P0AGE6; 2.
DR   STRING; 511145.b3713; -.
DR   EPD; P0AGE6; -.
DR   PaxDb; P0AGE6; -.
DR   PRIDE; P0AGE6; -.
DR   EnsemblBacteria; AAC76736; AAC76736; b3713.
DR   EnsemblBacteria; BAE77575; BAE77575; BAE77575.
DR   GeneID; 948225; -.
DR   KEGG; ecj:JW3691; -.
DR   KEGG; eco:b3713; -.
DR   PATRIC; 32122921; VBIEscCol129921_3836.
DR   EchoBASE; EB1674; -.
DR   EcoGene; EG11723; chrR.
DR   eggNOG; ENOG4108YYH; Bacteria.
DR   eggNOG; COG0431; LUCA.
DR   HOGENOM; HOG000263119; -.
DR   InParanoid; P0AGE6; -.
DR   KO; K19784; -.
DR   OMA; NKVDTQT; -.
DR   PhylomeDB; P0AGE6; -.
DR   BioCyc; EcoCyc:EG11723-MONOMER; -.
DR   BioCyc; MetaCyc:EG11723-MONOMER; -.
DR   PRO; PR:P0AGE6; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005829; C:cytosol; IDA:EcoCyc.
DR   GO; GO:0010181; F:FMN binding; IDA:EcoCyc.
DR   GO; GO:0052873; F:FMN reductase (NADPH) activity; IBA:GO_Central.
DR   GO; GO:0003955; F:NAD(P)H dehydrogenase (quinone) activity; IEA:UniProtKB-EC.
DR   GO; GO:0016491; F:oxidoreductase activity; IDA:EcoCyc.
DR   GO; GO:0006805; P:xenobiotic metabolic process; IMP:EcoCyc.
DR   Gene3D; 3.40.50.360; -; 1.
DR   InterPro; IPR029039; Flavoprotein-like_dom.
DR   InterPro; IPR005025; FMN_Rdtase-like.
DR   Pfam; PF03358; FMN_red; 1.
DR   SUPFAM; SSF52218; SSF52218; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Flavoprotein; FMN; NAD; NADP;
KW   Oxidoreductase; Reference proteome.
FT   CHAIN         1    188       Chromate reductase.
FT                                /FTId=PRO_0000160596.
FT   NP_BIND      13     20       FMN. {ECO:0000269|PubMed:22558308}.
FT   NP_BIND      82     85       FMN. {ECO:0000269|PubMed:22558308}.
FT   BINDING     117    117       FMN. {ECO:0000269|PubMed:22558308}.
FT   MUTAGEN      85     85       Y->N: Improves chromate reductase
FT                                activity compared to the wild-type
FT                                enzyme. {ECO:0000269|PubMed:22558308}.
FT   MUTAGEN     125    125       R->M: Improves chromate reductase
FT                                activity compared to the wild-type
FT                                enzyme. {ECO:0000269|PubMed:22558308}.
FT   MUTAGEN     128    128       Y->N: Improves chromate reductase
FT                                activity compared to the wild-type
FT                                enzyme. Increase of the affinity binding
FT                                and catalytic efficiency for both
FT                                chromate and uranate.
FT                                {ECO:0000269|PubMed:17088379}.
FT   MUTAGEN     146    146       E->T: Improves chromate reductase
FT                                activity compared to the wild-type
FT                                enzyme. {ECO:0000269|PubMed:22558308}.
FT   STRAND        5     11       {ECO:0000244|PDB:3SVL}.
FT   HELIX        19     26       {ECO:0000244|PDB:3SVL}.
FT   HELIX        27     29       {ECO:0000244|PDB:3SVL}.
FT   STRAND       35     39       {ECO:0000244|PDB:3SVL}.
FT   HELIX        51     56       {ECO:0000244|PDB:3SVL}.
FT   HELIX        61     72       {ECO:0000244|PDB:3SVL}.
FT   STRAND       73     80       {ECO:0000244|PDB:3SVL}.
FT   HELIX        89     99       {ECO:0000244|PDB:3SVL}.
FT   TURN        105    108       {ECO:0000244|PDB:3SVL}.
FT   STRAND      110    116       {ECO:0000244|PDB:3SVL}.
FT   TURN        120    123       {ECO:0000244|PDB:3SVL}.
FT   HELIX       124    136       {ECO:0000244|PDB:3SVL}.
FT   STRAND      147    149       {ECO:0000244|PDB:3SVL}.
FT   HELIX       152    155       {ECO:0000244|PDB:3SVL}.
FT   TURN        158    161       {ECO:0000244|PDB:3SVL}.
FT   HELIX       166    182       {ECO:0000244|PDB:3SVL}.
SQ   SEQUENCE   188 AA;  20376 MW;  78E163CC4826905D CRC64;
     MSEKLQVVTL LGSLRKGSFN GMVARTLPKI APASMEVNAL PSIADIPLYD ADVQQEEGFP
     ATVEALAEQI RQADGVVIVT PEYNYSVPGG LKNAIDWLSR LPDQPLAGKP VLIQTSSMGV
     IGGARCQYHL RQILVFLDAM VMNKPEFMGG VIQNKVDPQT GEVIDQGTLD HLTGQLTAFG
     EFIQRVKI
//
